Clinical trials
Immunoblastic Lymphadenopathy trials in the United States with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Terminated | 4 |
| Withdrawn | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fred Hutchinson Cancer Center | 4 |
| Mayo Clinic | 2 |
| Wake Forest University Health Sciences | 2 |
| Astex Pharmaceuticals, Inc. | 1 |
| Case Comprehensive Cancer Center | 1 |
| City of Hope Medical Center | 1 |
| Eastern Cooperative Oncology Group | 1 |
| M.D. Anderson Cancer Center | 1 |
| Ohio State University Comprehensive Cancer Center | 1 |
| Roswell Park Cancer Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Immunoblastic Lymphadenopathy | 17 |
| Lymphoma, Large-Cell, Anaplastic | 17 |
| Lymphoma, Large B-Cell, Diffuse | 16 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 15 |
| Burkitt Lymphoma | 14 |
| Lymphoma, Follicular | 14 |
| Lymphoma, Mantle-Cell | 14 |
| Mycosis Fungoides | 14 |
| Sezary Syndrome | 14 |
| Lymphoma, B-Cell, Marginal Zone | 13 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.